137 related articles for article (PubMed ID: 26982394)
21. Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.
Bird ST; Hartzema AG; Etminan M; Brophy JM; Delaney JA
Gynecol Endocrinol; 2013 Apr; 29(4):365-9. PubMed ID: 23311996
[TBL] [Abstract][Full Text] [Related]
22. Insulin Sensitizers for Treatment of Menstrual Irregularities Associated with PCOS.
Sokhal D; Kraus C
Am Fam Physician; 2015 Sep; 92(5):390. PubMed ID: 26371573
[No Abstract] [Full Text] [Related]
23. Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
Hanjalic-Beck A; Gabriel B; Schaefer W; Zahradnik HP; Schories M; Tempfer C; Keck C; Denschlag D
Gynecol Endocrinol; 2010 Sep; 26(9):690-7. PubMed ID: 20626240
[TBL] [Abstract][Full Text] [Related]
24. Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome.
Krstevska B; Dimitrovski Ch; Pemovska G; Misevska S; Dimova Z; Simeonova S; Ahmeti I
Prilozi; 2006 Jul; 27(1):57-66. PubMed ID: 16862066
[TBL] [Abstract][Full Text] [Related]
25. Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome.
Zafar S
J Ayub Med Coll Abbottabad; 2005; 17(4):54-6. PubMed ID: 16599037
[TBL] [Abstract][Full Text] [Related]
26. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).
Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
J Adolesc Health; 2001 Sep; 29(3):160-9. PubMed ID: 11524214
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance in polycystic ovarian disease.
Bhatia V
South Med J; 2005 Sep; 98(9):903-10; quiz 911-2, 923. PubMed ID: 16217983
[TBL] [Abstract][Full Text] [Related]
28. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Altinok ML; Ravn P; Andersen M; Glintborg D
Gynecol Endocrinol; 2018 Oct; 34(10):859-863. PubMed ID: 29658344
[TBL] [Abstract][Full Text] [Related]
29. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
[TBL] [Abstract][Full Text] [Related]
30. Novel strategies in the management of polycystic ovary syndrome.
Spritzer PM; Motta AB; Sir-Petermann T; Diamanti-Kandarakis E
Minerva Endocrinol; 2015 Sep; 40(3):195-212. PubMed ID: 25781065
[TBL] [Abstract][Full Text] [Related]
31. Metformin therapy in women with polycystic ovary syndrome.
Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
[TBL] [Abstract][Full Text] [Related]
32. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
Wang HS
Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
[TBL] [Abstract][Full Text] [Related]
33. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
[TBL] [Abstract][Full Text] [Related]
34. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
36. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.
Elkind-Hirsch K; Marrioneaux O; Bhushan M; Vernor D; Bhushan R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2670-8. PubMed ID: 18460557
[TBL] [Abstract][Full Text] [Related]
37. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.
Curi DD; Fonseca AM; Marcondes JA; Almeida JA; Bagnoli VR; Soares JM; Baracat EC
Gynecol Endocrinol; 2012 Mar; 28(3):182-5. PubMed ID: 22309675
[TBL] [Abstract][Full Text] [Related]
38. Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments.
Garcia-Beltran C; Peyrou M; Navarro-Gascon A; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
Front Endocrinol (Lausanne); 2024; 15():1325230. PubMed ID: 38818508
[TBL] [Abstract][Full Text] [Related]
39. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
[TBL] [Abstract][Full Text] [Related]
40. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
